Research progress on multiple cell death pathways of podocytes in diabetic kidney disease

被引:0
|
作者
Can Yang
Zhen Zhang
Jieting Liu
Peijian Chen
Jialing Li
Haiying Shu
Yanhui Chu
Luxin Li
机构
[1] Mudanjiang Medical University,Heilongjiang Key Laboratory of Anti
[2] Mudanjiang Medical University,Fibrosis Biotherapy
[3] Mudanjiang Medical University,College of Life Sciences
来源
关键词
Diabetic kidney disease; Podocyte; Apoptosis; Autophagy; Endoplasmic reticulum stress; Pyroptosis; Necroptosis; Ferroptosis; Mitotic catastrophe;
D O I
暂无
中图分类号
学科分类号
摘要
Diabetic kidney disease (DKD) is the main cause of end-stage renal disease, and its clinical manifestations are progressive proteinuria, decreased glomerular filtration rate, and renal failure. The injury and death of glomerular podocytes are the keys to DKD. Currently, a variety of cell death modes have been identified in podocytes, including apoptosis, autophagy, endoplasmic reticulum (ER) stress, pyroptosis, necroptosis, ferroptosis, mitotic catastrophe, etc. The signaling pathways leading to these cell death processes are interconnected and can be activated simultaneously or in parallel. They are essential for cell survival and death that determine the fate of cells. With the deepening of the research on the mechanism of cell death, more and more researchers have devoted their attention to the underlying pathologic research and the drug therapy research of DKD. In this paper, we discussed the podocyte physiologic role and DKD processes. We also provide an overview of the types and specific mechanisms involved in each type of cell death in DKD, as well as related targeted therapy methods and drugs are reviewed. In the last part we discuss the complexity and potential crosstalk between various modes of cell death, which will help improve the understanding of podocyte death and lay a foundation for new and ideal targeted therapy strategies for DKD treatment in the future.
引用
收藏
相关论文
共 50 条
  • [31] Inhibition of mitochondrial fission protects podocytes from albumin-induced cell damage in diabetic kidney disease
    Tagaya, Makoto
    Kume, Shinji
    Yasuda-Yamahara, Mako
    Kuwagata, Shogo
    Yamahara, Kosuke
    Takeda, Naoko
    Tanaka, Yuki
    Chin-Kanasaki, Masami
    Nakae, Yuki
    Yokoi, Hideki
    Mukoyama, Masashi
    Ishihara, Naotada
    Nomura, Masatoshi
    Araki, Shin-ichi
    Maegawa, Hiroshi
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2022, 1868 (05):
  • [32] Remodeling of Purinergic Receptor 2 Signaling in Podocytes In Response to Diabetic Kidney Disease
    Klemens, Christine
    Palygin, Oleg
    Isaeva, Elena
    Levchenko, Vladislav
    Spires, Denisha
    Dissanayake, Lashodya
    Nikolaienko, Oksana
    Ilatovskaya, Dania
    Staruschenko, Alexander
    FASEB JOURNAL, 2021, 35
  • [33] (+)-Catechins Play a Protective Role in Diabetic Kidney Disease by Alleviating EMT through Multiple Pathways
    Ni, Ying
    Zhu, Dina
    Chen, Chao
    Wang, Fan
    Miu, Yanyan
    Zhang, Wensheng
    MOLECULAR NUTRITION & FOOD RESEARCH, 2024, 68 (17)
  • [34] New progress in drugs treatment of diabetic kidney disease
    Wang, Junmin
    Xiang, Hongjiao
    Lu, Yifei
    Wu, Tao
    Ji, Guang
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 141
  • [35] Cellular Senescence and Regulated Cell Death of Tubular Epithelial Cells in Diabetic Kidney Disease
    Shen, Shuang
    Ji, Chuanyuan
    Wei, Kaifeng
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [36] Podocyte programmed cell death in diabetic kidney disease: Molecular mechanisms and therapeutic prospects
    Yang, Haoyu
    Wei, Yu
    Sun, Jun
    Sun, Aru
    Xie, Weinan
    Xie, Pengfei
    Zhang, Lili
    Zhao, Linhua
    Huang, Yishan
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 177
  • [37] Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy
    Liu, Fengzhao
    Yang, Zhenyu
    Li, Jixin
    Wu, Tao
    Li, Xiangyu
    Zhao, Lijuan
    Wang, Wenru
    Yu, Wenfei
    Zhang, Guangheng
    Xu, Yunsheng
    MOLECULAR MEDICINE, 2024, 30 (01)
  • [38] The Role of Podocytes and Podocyte-Associated Biomarkers in Diagnosis and Treatment of Diabetic Kidney Disease
    Kravets, Igor
    Mallipattu, Sandeep K.
    JOURNAL OF THE ENDOCRINE SOCIETY, 2020, 4 (04)
  • [39] Vitamin D/VDR Protects Against Diabetic Kidney Disease by Restoring Podocytes Autophagy
    Song, Zhixia
    Xiao, Chao
    Jia, Xiaoli
    Luo, Chunhua
    Shi, Lang
    Xia, Rong
    Zhu, Jiefu
    Zhang, Shizhong
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 1681 - 1693
  • [40] Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes
    Yifei Zhong
    Kyung Lee
    Yueyi Deng
    Yueming Ma
    Yiping Chen
    Xueling Li
    Chengguo Wei
    Shumin Yang
    Tianming Wang
    Nicholas J. Wong
    Alecia N. Muwonge
    Evren U. Azeloglu
    Weijia Zhang
    Bhaskar Das
    John Cijiang He
    Ruijie Liu
    Nature Communications, 10